5 reports

  • 5.1.2 China & Taiwan
  • Enteral Stenting for Other Indications*

Stomach cancer and colorectal cancer are the two cancers with the highest incidence rates in Japan.

  • Cancer
  • Interventional Cardiology Device
  • Australia
  • China
  • Taiwan
  • MEDIGENE ENTERS INTO LICENSING AGREEMENT WITH SYNCORE BIOTECHNOLOGY FOR ENDOTAG-1

It was also under development for metastatic liver cancer.

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Taiwan
  • Sinphar Pharmaceutical Co., Ltd.
  • Senhwa Biosciences to Raise up to USD49.7 Million in Public Offering of Shares
  • Deal Rationale

Canadian Cancer Trials Group Canadian Cancer Trials Group (CCTG), formerly known as NCIC Clinical Trials Group, is a subsidiary of Cancer Research Institute at Queen' s University, is a contract research organization that conducts clinical trials.

  • Cancer
  • Taiwan
  • Company
  • Corporate Finance
  • Senhwa Biosciences, Inc.
  • 09/26/2016: FIRST PATIENT DOSED IN CANBRIDGE'S CAN-008 PHASE I/II TRIAL IN NEWLY- DIAGNOSED GLIOBLASTOMA MULTIFORME IN TAIWAN

HERA-GITRL is an immunotherapy showing antitumor activity in Non-Small Cell Lung Cancer (NSCLC) and Head and Neck Cancer.

  • Cancer
  • Pharmaceutical
  • Taiwan
  • Deals & Alliance
  • Product Initiative
  • PHARMAENGINE INC, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • LICENSING AGREEMENTS

The company' s products are used for the treatment of various type of cancers such as metastatic pancreatic cancer, head and neck cancer, oral cancer and colorectal cancer, among others.

  • Cancer
  • Pathology
  • Therapy
  • Taiwan
  • PharmaEngine, Inc.